Peter Dogterom
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Pharmacokinetics and safety of TBAJ-587, a novel antimycobacterial diarylquinoline, in healthy participants.
Journal: Antimicrobial agents and chemotherapy
Published: July 28, 2026
Further elucidation on the effect of food on the pharmacokinetics of trientine.
Journal: European journal of clinical pharmacology
Published: July 21, 2025
New insights into the effects of dissolution profiles on the pharmacokinetics of trientine dihydrochloride.
Journal: European journal of clinical pharmacology
Published: July 21, 2025
Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1).
Journal: Cancer chemotherapy and pharmacology
Published: June 27, 2024
A Phase 1 First-in-Human Single-Ascending-Dose Trial With ESB1609, a Selective Agonist to the Sphingosine-1-Phosphate Receptor 5.
Journal: Clinical pharmacology in drug development
Published: November 03, 2022
Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study.
Journal: Neurology and therapy
Published: April 26, 2022
Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects.
Journal: European journal of drug metabolism and pharmacokinetics
Published: June 29, 2021
Effect of Rifampin-Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist Selatogrel.
Journal: Clinical and translational science
Published: January 02, 2020
Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet Aggregation.
Journal: Journal of clinical pharmacology
Published: November 29, 2019
Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 25, 2019
Influence of Rifampin-Mediated Organic Anion-Transporting Polypeptide 1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan.
Journal: Clinical and translational science
Published: February 22, 2019
Asenapine pharmacokinetics and tolerability in a pediatric population.
Journal: Drug design, development and therapy
Published: September 15, 2018
Last Updated: 09/26/2026